تقييم فعالية مركبات الكينولون في علاج التهاب الأذن الوسطى القيحي المزمن

Authors

  • فايز العلوني
  • محمد الرستم
  • أكثم شريبا

Abstract

تم تقييم 200 مريض مصاب بالتهاب أذن وسطى قيحي مزمن بعد تقسيمهم إلى 3 مجموعات وعلاجهم بثلاث طرق علاجية بمركبات الكينولون، ضمت كل من المجموعة الأولى و الثانية 70 مريضاً وضمت المجموعة الثالثة 60 مريضاً، عولجت المجموعة الاولى بالكينولونات موضعيا ( مع أو دون ستيروئيد)، وعولجت المجموعة الثانية بالكينولونات فمويا، أما المجموعة الثالثة فقد عولجت بالمشاركة بين الكينولونات موضعيا وفمويا.

وبينت الدراسة فعالية مركبات الكينولون موضعيا في علاج 66 مريضاً ( 94.28% ) من المجموعة الأولى، كما تم شفاء 26 مريضاً ( 37.14%) من المجموعة الثانية بعد علاجهم بالكينولونات فمويا، أما مرضى المجموعة الثالثة فقد تم شفاء 58 مريضاً ( 96.66% ) بعد علاجهم بالكينولونات موضعيا وفموياً.

Two hundred patients with Chronic suppurative Otitis Media (CSOM) were divided into three groups, each of the first and second groups(A,B) contained 70 patients and the third group(C) contained 60 patients. Group A was treated with topical quinolone (with or without steroid). Group B was treated with oral quinolone and Group C was treated with topical and oral quinolones.

The study concludes that 66 patients (94.28%) of Group A were cured, 26 patients (37.14%) of Group B were cured and 58 patients (96.66%) of Group C were cured.

Downloads

Published

2019-01-20

How to Cite

1.
العلوني ف, الرستم م, شريبا أ. تقييم فعالية مركبات الكينولون في علاج التهاب الأذن الوسطى القيحي المزمن. Tuj-hlth [Internet]. 2019Jan.20 [cited 2024Nov.24];32(2). Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/6701

Issue

Vol. 32 No. 2 (2010): العلوم الصحية

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.